US 11,850,424 B2
Stimulation for treating sleep disordered breathing
Darrell Wagner, Ham Lake, MN (US); Quan Ni, Shoreview, MN (US); John Rondoni, Plymouth, MN (US); and David Dieken, Minneapolis, MN (US)
Assigned to INSPIRE MEDICAL SYSTEMS, INC., Golden Valley, MN (US)
Filed by INSPIRE MEDICAL SYSTEMS, INC., Golden Valley, MN (US)
Filed on Jun. 16, 2021, as Appl. No. 17/348,852.
Application 17/348,852 is a continuation of application No. 17/012,481, filed on Sep. 4, 2020, granted, now 11,806,526.
Application 17/012,481 is a continuation of application No. 15/562,714, granted, now 10,898,709, issued on Jan. 26, 2021, previously published as PCT/US2016/022611, filed on Mar. 16, 2016.
Claims priority of provisional application 62/135,305, filed on Mar. 19, 2015.
Prior Publication US 2021/0308454 A1, Oct. 7, 2021
Int. Cl. A61N 1/36 (2006.01); A61B 5/08 (2006.01); A61B 5/00 (2006.01); G16H 20/40 (2018.01); A61B 5/113 (2006.01); A61B 5/0205 (2006.01)
CPC A61N 1/3601 (2013.01) [A61B 5/0816 (2013.01); A61B 5/0826 (2013.01); A61B 5/113 (2013.01); A61B 5/4818 (2013.01); A61B 5/4848 (2013.01); A61B 5/686 (2013.01); A61N 1/3611 (2013.01); G16H 20/40 (2018.01); A61B 5/0205 (2013.01); A61N 1/3614 (2017.08); A61N 1/36146 (2013.01); A61N 1/36171 (2013.01)] 21 Claims
OG exemplary drawing
 
1. A device for treating obstructive sleep disordered breathing, comprising:
a means for stimulating a hypoglossal nerve, according to a first stimulation therapy protocol including alternating periods of stimulation and non-stimulation in which a timing of the stimulation periods is implemented without a sensing element for timing stimulation,
wherein a duration of each respective stimulation period is greater than a duration of each respective non-stimulation period, wherein the duration of each respective stimulation period is based on a reference respiration-related parameter, and
wherein the means for stimulating comprises an implantable electrode and/or an implantable pulse generator electrically connectable to the implantable electrode.